Main Sequence Ventures is located in North Ryde, Australia on Building 52/5 Julius Ave. Main Sequence Ventures is rated 3 out of 5 in the category venture capital & private equity in Australia. We back deep-tech founders inventing tomorrow. Main Sequence Ventures is managing the CSIRO Innovation Fund 1, LP – part of the Australian Government’s National Innovation and Science Agenda, custom designed for a new kind of founder in which science and technology run deep. We will invest in companies translating research into global-scale businesses. We know that this takes more than money. We work harder to understand the world that these founders imagine. We are as comfortable in the lab as we are on the front-line with customers. We will invest capital, and ourselves, to systematically reduce risk and increase opportunity by combining the operational velocity of startups with the deep curiosity of Australia’s research sector. We believe the next great cohort of disruptive companies will come from those scientists, technologists and creative thinkers who are prepared to challenge the status quo.
Address
Building 52/5 Julius Ave
Company size
1-10 employees
Headquarters
North Ryde, NSW
Accessibility
Wheelchair-accessible entrance